BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lodewijk I, Dueñas M, Rubio C, Munera-Maravilla E, Segovia C, Bernardini A, Teijeira A, Paramio JM, Suárez-Cabrera C. Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring. Int J Mol Sci 2018;19:E2514. [PMID: 30149597 DOI: 10.3390/ijms19092514] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Hou Y, Yang C, Liu C, Gao L, Ma Z, Yu Y, Wang W. Quantitative detection of urinary bladder cancer antigen via peptide-immobilized magnetic bead-based SERS probe. Anal Bioanal Chem 2022. [DOI: 10.1007/s00216-022-04361-4] [Reference Citation Analysis]
2 Walker JM, O’malley P, He M. Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer. Pharmaceutics 2022;14:2027. [DOI: 10.3390/pharmaceutics14102027] [Reference Citation Analysis]
3 Suarez-Cabrera C, Estudillo L, Ramón-Gil E, Martínez-Fernández M, Peral J, Rubio C, Lodewijk I, Martín de Bernardo Á, García-Escudero R, Villacampa F, Duarte J, de la Rosa F, Castellano D, Guerrero-Ramos F, Real FX, Malats N, Paramio JM, Dueñas M. BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up. Eur Urol 2022:S0302-2838(22)02562-3. [PMID: 36085102 DOI: 10.1016/j.eururo.2022.08.011] [Reference Citation Analysis]
4 Wei X, Cai Z, Cai L, Wang Y, Zhang D, Zhu Y. Photonic Barcodes Combining Branched Hybridization Chain Reaction for Multiplex Quantification of Bladder Cancer MicroRNAs. Adv Materials Inter. [DOI: 10.1002/admi.202102515] [Reference Citation Analysis]
5 Zhu K, Liu X, Deng W, Wang G, Fu B. Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer. Hereditas 2022;159. [DOI: 10.1186/s41065-021-00212-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Shishido SN, Sayeed S, Courcoubetis G, Djaladat H, Miranda G, Pienta KJ, Nieva J, Hansel DE, Desai M, Gill IS, Kuhn P, Mason J. Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer. Cancers (Basel) 2022;14:758. [PMID: 35159025 DOI: 10.3390/cancers14030758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Santos V, Freitas C, Fernandes MG, Sousa C, Reboredo C, Cruz-martins N, Mosquera J, Hespanhol V, Campelo R. Liquid biopsy: the value of different bodily fluids. Biomarkers in Medicine. [DOI: 10.2217/bmm-2021-0370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Salah Fararjeh A, Al-Khader A, Al-Saleem M, Abu Qauod R. The Prognostic Significance of Proteasome 26S Subunit, Non-ATPase (PSMD) Genes for Bladder Urothelial Carcinoma Patients. Cancer Inform 2021;20:11769351211067692. [PMID: 34992336 DOI: 10.1177/11769351211067692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Merae Alshahrani M. A glance at the emerging diagnostic biomarkers in the most prevalent genitourinary cancers. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.01.017] [Reference Citation Analysis]
10 Cavallari I, Ciccarese F, Sharova E, Urso L, Raimondi V, Silic-Benussi M, D'Agostino DM, Ciminale V. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. Cancers (Basel) 2021;13:5874. [PMID: 34884985 DOI: 10.3390/cancers13235874] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
11 Jain M, Kamalov D, Tivtikyan A, Balatsky A, Samokhodskaya L, Okhobotov D, Kozlova P, Pisarev E, Zvereva M, Kamalov A. Urine TERT promoter mutations-based tumor DNA detection in patients with bladder cancer: A pilot study. Mol Clin Oncol 2021;15:253. [PMID: 34712485 DOI: 10.3892/mco.2021.2415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Fan B, Huang Y, Wen S, Teng Q, Yang X, Sun M, Chen T, Huang Y, Wang Y, Liu Z. Predictive Value of Preoperative Positive Urine Cytology for Development of Bladder Cancer After Nephroureterectomy in Patients With Upper Urinary Tract Urothelial Carcinoma: A Prognostic Nomogram Based on a Retrospective Multicenter Cohort Study and Systematic Meta-Analysis. Front Oncol 2021;11:731318. [PMID: 34660295 DOI: 10.3389/fonc.2021.731318] [Reference Citation Analysis]
13 Zhao Y, Zhao B, Yan WH, Xia Y, Wang ZH, Zheng GY, Wang WD, Zhang YS. Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer. Front Oncol 2021;11:704857. [PMID: 34513685 DOI: 10.3389/fonc.2021.704857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Testa A, Venturelli E, Brizzi MF. Extracellular Vesicles: New Tools for Early Diagnosis of Breast and Genitourinary Cancers. Int J Mol Sci 2021;22:8430. [PMID: 34445131 DOI: 10.3390/ijms22168430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Loras A, Segovia C, Ruiz-Cerdá JL. Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer. Cancers (Basel) 2021;13:2719. [PMID: 34072826 DOI: 10.3390/cancers13112719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Zang J, Ye K, Fei Y, Zhang R, Chen H, Zhuang G. Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis. Front Oncol 2021;11:696716. [PMID: 34123863 DOI: 10.3389/fonc.2021.696716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Barani M, Hosseinikhah SM, Rahdar A, Farhoudi L, Arshad R, Cucchiarini M, Pandey S. Nanotechnology in Bladder Cancer: Diagnosis and Treatment. Cancers (Basel) 2021;13:2214. [PMID: 34063088 DOI: 10.3390/cancers13092214] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 33.0] [Reference Citation Analysis]
18 Martínez-Rojo E, Berumen LC, García-Alcocer G, Escobar-Cabrera J. The Role of Androgens and Androgen Receptor in Human Bladder Cancer. Biomolecules 2021;11:594. [PMID: 33919565 DOI: 10.3390/biom11040594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Ferro M, La Civita E, Liotti A, Cennamo M, Tortora F, Buonerba C, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, de Cobelli O, Carrieri G, Porreca A, Cimmino A, Terracciano D. Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer. J Pers Med 2021;11:237. [PMID: 33806972 DOI: 10.3390/jpm11030237] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 32.0] [Reference Citation Analysis]
20 Cai YX, Yang X, Lin S, Xu YW, Zhu SW, Fan DM, Zhao M, Zhang YB, Yang XX, Li X. Low-Coverage Sequencing of Urine Sediment DNA for Detection of Copy Number Aberrations in Bladder Cancer. Cancer Manag Res 2021;13:1943-53. [PMID: 33664588 DOI: 10.2147/CMAR.S295675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hammouz RY, Kołat D, Kałuzińska Ż, Płuciennik E, Bednarek AK. MicroRNAs: Their Role in Metastasis, Angiogenesis, and the Potential for Biomarker Utility in Bladder Carcinomas. Cancers (Basel) 2021;13:891. [PMID: 33672684 DOI: 10.3390/cancers13040891] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
22 Piao XM, Cha EJ, Yun SJ, Kim WJ. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker. Int J Mol Sci 2021;22:1713. [PMID: 33567779 DOI: 10.3390/ijms22041713] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
23 Carvalho FLF, Salari K. Novel and Investigational Diagnostics: Liquid Biopsy and Beyond. Comprehensive Diagnostic Approach to Bladder Cancer 2021. [DOI: 10.1007/978-3-030-82048-0_12] [Reference Citation Analysis]
24 Kang HW, Kim WJ, Choi W, Yun SJ. Tumor heterogeneity in muscle-invasive bladder cancer. Transl Androl Urol 2020;9:2866-80. [PMID: 33457261 DOI: 10.21037/tau.2020.03.13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Cavallari I, Grassi A, Del Bianco P, Aceti A, Zaborra C, Sharova E, Bertazzolo I, D'Agostino DM, Iafrate M, Ciminale V. Prognostic Stratification of Bladder Cancer Patients with a MicroRNA-based Approach. Cancers (Basel) 2020;12:E3133. [PMID: 33114775 DOI: 10.3390/cancers12113133] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
26 Kang HW, Kim WJ, Yun SJ. The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma. Transl Cancer Res 2020;9:6609-23. [PMID: 35117271 DOI: 10.21037/tcr-20-1243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Jiang F, Li C, Han J, Wang L. Diagnostic Value of Combination of MicroRNA-192 in Urinary Sediment and B-Ultrasound for Bladder Cancer. Technol Cancer Res Treat 2020;19:1533033819894573. [PMID: 32106776 DOI: 10.1177/1533033819894573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 Othman HO, Salehnia F, Hosseini M, Hassan R, Faizullah A, Ganjali MR. Fluorescence immunoassay based on nitrogen doped carbon dots for the detection of human nuclear matrix protein NMP22 as biomarker for early stage diagnosis of bladder cancer. Microchemical Journal 2020;157:104966. [DOI: 10.1016/j.microc.2020.104966] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
29 Lobo J, Monteiro-Reis S, Guimarães-Teixeira C, Lopes P, Carneiro I, Jerónimo C, Henrique R. Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression. J Transl Med 2020;18:303. [PMID: 32758253 DOI: 10.1186/s12967-020-02475-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
30 Chaudhuri AA, Pellini B, Pejovic N, Chauhan PS, Harris PK, Szymanski JJ, Smith ZL, Arora VK. Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management. JCO Precis Oncol 2020;4:PO. [PMID: 32923907 DOI: 10.1200/PO.20.00060] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Chen CK, Liao J, Li MS, Khoo BL. Urine biopsy technologies: Cancer and beyond. Theranostics 2020;10:7872-88. [PMID: 32685026 DOI: 10.7150/thno.44634] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
32 Spagnuolo M, Costantini M, Ferriero M, Varmi M, Sperduti I, Regazzo G, Cicchillitti L, Díaz Méndez AB, Cigliana G, Pompeo V, Russo A, Laquintana V, Mastroianni R, Piaggio G, Anceschi U, Brassetti A, Bove A, Tuderti G, Flammia RS, Gallucci M, Simone G, Rizzo MG. Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study. J Exp Clin Cancer Res 2020;39:68. [PMID: 32303246 DOI: 10.1186/s13046-020-01550-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
33 Lei Q, Zhao L, Ye S, Sun Y, Xie F, Zhang H, Zhou F, Wu S. Rapid and quantitative detection of urinary Cyfra21-1 using fluorescent nanosphere-based immunochromatographic test strip for diagnosis and prognostic monitoring of bladder cancer. Artif Cells Nanomed Biotechnol 2019;47:4266-72. [PMID: 31842631 DOI: 10.1080/21691401.2019.1687491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
34 Tang Q, Hann SS. Biological Roles and Mechanisms of Circular RNA in Human Cancers. Onco Targets Ther 2020;13:2067-92. [PMID: 32210574 DOI: 10.2147/OTT.S233672] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 44.0] [Reference Citation Analysis]
35 Rose M, Bringezu S, Godfrey L, Fiedler D, Gaisa NT, Koch M, Bach C, Füssel S, Herr A, Hübner D, Ellinger J, Pfister D, Knüchel R, Wirth MP, Böhme M, Dahl E. ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer. Int J Mol Sci 2020;21:E1117. [PMID: 32046186 DOI: 10.3390/ijms21031117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
36 Reis H, Szarvas T. [Predictive biomarkers in bladder cancer]. Pathologe 2019;40:331-8. [PMID: 31705236 DOI: 10.1007/s00292-019-00688-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Yu X, Wang R, Han C, Wang Z, Jin X. A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis. J Cancer 2020;11:781-7. [PMID: 31949480 DOI: 10.7150/jca.37006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
38 Ghosh G. Early detection of cancer: Focus on antibody coated metal and magnetic nanoparticle-based biosensors. Sensors International 2020;1:100050. [DOI: 10.1016/j.sintl.2020.100050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
39 Martinez VG, Munera-Maravilla E, Bernardini A, Rubio C, Suarez-Cabrera C, Segovia C, Lodewijk I, Dueñas M, Martínez-Fernández M, Paramio JM. Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet. Front Genet 2019;10:1125. [PMID: 31850055 DOI: 10.3389/fgene.2019.01125] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
40 Kouba E, Lopez-Beltran A, Montironi R, Massari F, Huang K, Santoni M, Chovanec M, Cheng M, Scarpelli M, Zhang J, Cimadamore A, Cheng L. Liquid biopsy in the clinical management of bladder cancer: current status and future developments. Expert Rev Mol Diagn 2020;20:255-64. [PMID: 31608720 DOI: 10.1080/14737159.2019.1680284] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
41 Wang Y, Chen L, Ju L, Qian K, Liu X, Wang X, Xiao Y. Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis. Front Oncol 2019;9:1030. [PMID: 31681575 DOI: 10.3389/fonc.2019.01030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
42 Bellassai N, D'Agata R, Jungbluth V, Spoto G. Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis. Front Chem 2019;7:570. [PMID: 31448267 DOI: 10.3389/fchem.2019.00570] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 25.0] [Reference Citation Analysis]
43 Dvorská D, Škovierová H, Braný D, Halašová E, Danková Z. Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri. Int J Mol Sci 2019;20:E3825. [PMID: 31387281 DOI: 10.3390/ijms20153825] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
44 Loras A, Martínez-Bisbal MC, Quintás G, Gil S, Martínez-Máñez R, Ruiz-Cerdá JL. Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer. Cancers (Basel) 2019;11:E914. [PMID: 31261883 DOI: 10.3390/cancers11070914] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
45 Setti Boubaker N, Cicchillitti L, Said R, Gurtner A, Ayed H, Blel A, Karray O, Essid MA, Gharbi M, Bouzouita A, Rammeh Rommeni S, Chebil M, Piaggio G, Ouerhani S. The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer. Mol Biol Rep 2019;46:4743-50. [DOI: 10.1007/s11033-019-04920-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
46 Amara CS, Vantaku V, Lotan Y, Putluri N. Recent advances in the metabolomic study of bladder cancer. Expert Rev Proteomics 2019;16:315-24. [PMID: 30773067 DOI: 10.1080/14789450.2019.1583105] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]